| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 06/09/2005 | WO2005051950A1 Novel 8-(piperazine-1-yl)- and 8-([1,4]diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug |
| 06/09/2005 | WO2005051944A1 Heterocyclyl-substituted oxetanes for the treatment of proliferative or infectious diseases |
| 06/09/2005 | WO2005051286A2 Stable ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-yloxy) methyl)-2-amine-1h-purin-6(9h)-one. |
| 06/09/2005 | US20050124637 For example, {4-[2-(4-Amino-cyclohexylamino)-9-phenyl-9H-purin-6-ylamino]-phenyl}-piperidin-1-yl-methanone; inhibit the activity of one or more protein kinases and are, therefore, expected to be useful in the treatment of kinase-associated diseases |
| 06/09/2005 | US20050124582 2-amino-6-substituted-9-[(2-hydroxymethyl or phosphatomethyl)cyclopropylidenemethyl]purines; herpes viruses, cytomegalo virus, Epstein-Barr virus, HIV |
| 06/09/2005 | US20050124532 Using nucleoside, or prodrug thereof |
| 06/09/2005 | US20050123597 Releasable linkage and compositions containing same |
| 06/09/2005 | CA2546733A1 A2b adenosine receptor antagonists |
| 06/09/2005 | CA2544480A1 Novel 8-(piperazine-1-yl)- and 8-([1,4]diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug |
| 06/08/2005 | EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 06/08/2005 | EP1537111A1 Hetereoaryl nitrile derivatives |
| 06/08/2005 | EP1176146B1 Carbamoyl tetrahydropyridine derivatives |
| 06/07/2005 | US6903224 Substituted with purine or pyrimidine bases |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/07/2005 | US6903079 Nucleoside compounds and compositions thereof |
| 06/07/2005 | CA2209598C Aryl and heteroaryl purine compounds |
| 06/02/2005 | WO2005049613A1 Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 06/02/2005 | WO2005049582A1 Method of preparation of novel nucleoside analogs and uses |
| 06/02/2005 | WO2005048953A2 Amide derivatives as kinase modulators |
| 06/02/2005 | WO2005048948A2 Urea derivatives as kinase modulators |
| 06/02/2005 | WO2004074247A3 A1 adenosine receptor antagonists |
| 06/02/2005 | US20050119282 Pyrazolopyrimidines and related analogs as HSP90-inhibitors |
| 06/02/2005 | US20050119258 Xanthines 3-and 8-substituted with an arylalkylene or heteroarylalkylene, e.g. 3-[2-(4-Aminophenyl)ethyl]-8-benzyl-1-propylxanthine and 3-[2-(4-Aminophenyl)ethyl]-1-propyl-8-[(3-pyridyl)methyl]xanthine |
| 06/02/2005 | US20050119214 Nuclease resistant double-stranded ribonucleic acid |
| 06/02/2005 | CA2545725A1 Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 06/02/2005 | CA2545711A1 Urea derivatives as kinase modulators |
| 06/01/2005 | EP1535923A1 Synthesis of acyclic nucleoside derivatives |
| 06/01/2005 | EP1535921A1 Method of manufacture of 1,3-oxathiolane nucleosides |
| 06/01/2005 | EP1534708A2 Purine derivatives and their use as antiproliferative agents |
| 06/01/2005 | EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 06/01/2005 | EP1534255A2 Processes for preparing 1,3-dioxolane nucleosides |
| 06/01/2005 | EP0794963B1 Xanthine derivatives compounds useful for activating chloride conductance in animal cells |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/26/2005 | WO2005047526A2 Method for identifying inhibitors using a homology model of polo-like kinase 1 |
| 05/26/2005 | WO2005047524A2 Compositions and methods for inducing cell dedifferentiation |
| 05/26/2005 | US20050113393 Treating human herpes virus, human immunodeficiency virus, and hepatitis B virus; optionally administered with other antiviral agents; (E)-9-{[2,2-bis-(hydroxymethyl)cyclopropylidene]methyl}adenine |
| 05/26/2005 | US20050113378 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |
| 05/26/2005 | US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis |
| 05/26/2005 | US20050113340 9-(Substituted aryl, heteroaryl, alicyclyl, or heterocyclyl)methyl-2-amino-6-halopurines, e.g., 6-chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine; used in the treatment and prevention of various Heat Shock Protein 90 mediated disorders, e.g., proliferative disorders |
| 05/26/2005 | US20050113339 inflammatory diseases, infections, autoimmune disorders, stroke, ischemia, cardiac disorder, neurological disorders, fibrogenetic disorders, proliferative disorders, tumors, leukemias, neoplasms, cancers, carcinomas, metabolic diseases, and malignant disease |
| 05/25/2005 | EP1532151A2 Crystalline solid famciclovir forms i, ii, iii and preparation thereof |
| 05/25/2005 | EP1532150A1 Novel purine derivatives, production and use thereof as medicaments |
| 05/25/2005 | EP1532149A2 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 05/25/2005 | EP1532148A1 Novel purine- or pyrrolol(2,3-d)pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activity |
| 05/25/2005 | EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 05/25/2005 | EP1531815A1 Glucokinase activators |
| 05/24/2005 | US6897307 Process for preparing 2,6-diaminopurine derivatives |
| 05/24/2005 | US6897220 Antiproliferative agents |
| 05/19/2005 | US20050107343 Pyrrolo[2,3-d]pyrimidin-2-ylamines substituted in the 7th position by a aryl, heteroaryl, alicyclic, or heterocyclic group connected by methyl, C(O) , C(S) , S(O) or SO2; used in the treatment and prevention of various Heat Shock Protein 90 mediated disorders, e.g., proliferative disorders |
| 05/19/2005 | US20050107325 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs |
| 05/19/2005 | US20050106652 Detecting coliform bacteria in food liquids and/or homogenates; immunoassay |
| 05/18/2005 | CN1617871A Purine derivatives as purinergic receptor antagonists |
| 05/18/2005 | CN1616459A Adenosine derivatives |
| 05/18/2005 | CN1202118C Adenosine derivatives |
| 05/17/2005 | US6894168 Carbamoyl tetrahydropyridine derivatives |
| 05/17/2005 | US6894045 Tetrahydropurinones and derivatives thereof as corticotropin releasing factor receptor ligands |
| 05/17/2005 | US6893815 Nucleobase heterocyclic combinatorialization |
| 05/12/2005 | WO2005016528A3 6-substituted anilino purines as rtk inhibitors |
| 05/12/2005 | WO2005009343A3 A1 adenosine receptor antogonists |
| 05/12/2005 | WO2005003100A3 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 05/12/2005 | US20050101778 A2B adenosine receptor antagonists |
| 05/12/2005 | US20050101776 2' or 3' -deoxy and 2' , 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents |
| 05/12/2005 | US20050101570 Preparation of purines |
| 05/11/2005 | EP1529049A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 05/11/2005 | EP1529048A2 Methods for the synthesis of substituted purines |
| 05/11/2005 | EP1529047A2 New purine derivatives |
| 05/11/2005 | EP1470114A4 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 05/11/2005 | CN1615299A Xanthine oxidase inhibitors |
| 05/10/2005 | US6890926 Antitumor agents |
| 05/10/2005 | CA2320474C 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino]purines |
| 05/05/2005 | US20050096331 Alkyl carboxylic acids and their derivatives; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds; better efficacy, potency and lower toxicity |
| 05/05/2005 | US20050096308 Antibacterial agents |
| 05/05/2005 | US20050096293 Analogs of nitrobenzylthioinosine |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP0882050B2 Process for preparing purine derivatives |
| 05/04/2005 | CN1612878A Synthesis and purification of valacyclovir |
| 05/04/2005 | CN1199972C Alkali condensation and phase transfer catalysis process synthesizing 6-benzylaminopurine |
| 05/03/2005 | US6887880 Preventing or inhibiting a patient's fibroproliferative vasculopathy following vascular injury or a vascular surgical operation; treating chronic allograft rejection or vascular restenosis following vascular trauma. |
| 04/28/2005 | WO2005037835A1 Novel thioxanthine derivatives for use as inhibitors of mpo |
| 04/28/2005 | US20050090666 Acylation with acetic anhydride in presence of base (triethylamine); diazotization |
| 04/28/2005 | US20050090472 Xanthine oxidase inhibitors |
| 04/27/2005 | EP1131323B1 Synthesis of acyclic nucleoside derivatives |
| 04/27/2005 | CN1198825C 8-pheyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 04/21/2005 | WO2002057425A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/21/2005 | US20050085638 Process for producing dioxolane nucleoside analogues |
| 04/21/2005 | US20050085491 Novel crystalline forms of valacyclovir hydrochloride |
| 04/19/2005 | US6881753 Potassium channel inhibitors and method |
| 04/19/2005 | US6881536 Particle based electrochemiluminescent assays |
| 04/14/2005 | US20050080261 {(2-hydroxyethyl)[9-(methylethyl)-6-(3-quinolylamino)purin-2-yl]amino}ethan-1-ol; antiproliferatives, treating rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, cancer, restenosis, host graft disease, and gout |
| 04/14/2005 | US20050080098 Crystal and solvate of 2-amino-6-benzyloxypurine and production methods thereof |
| 04/14/2005 | US20050080003 Compounds with anti-inflammatory activity |
| 04/13/2005 | EP1521584A1 Purine derivatives as liver x receptor agonists |
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1196701C Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of 1-3-oxaselenolane nucleosides |
| 04/12/2005 | US6878844 Synthesis of acyclic nucleoside derivatives |
| 04/12/2005 | US6878715 Xanthine derivatives such as 1-(5-N,N-dimethylaminohexyl)-3,7-dimethylxanthine |
| 04/07/2005 | WO2005030754A1 Indole or quinoline derivatives as non-pepticid npy y2 receptor inhibitors useful for the treatment of anxiolytic and depressive disorders and obesity |
| 04/07/2005 | WO2005030219A1 Method of stabilizing diarylvinylene compound |
| 04/07/2005 | US20050075349 Xanthine phosphodiesterase V inhibitors |